The Academy of Surgical Innovation (ASI) stands as the Global Surgical Excellence Campus — a multidisciplinary hub where biotech, bioengineering, bioindustry, and clinical medicine converge to shape the future of healthcare.
As the nucleus of this ecosystem, ASI unites a vast network of education, biomedicine, clinical research, and technology transfer within one seamless platform. Through its integrated affiliates — CYNTAR Hospital, a Surgical Innovation and Clinical Research Hub, and the International Institute of Metabolic Medicine (IIMM) — ASI enables the full cycle of innovation, validation, and application: from simulation to surgery, from research to real-world outcomes, and from concept to patient benefit.

ASI is a real-world lab where bioindustry and tech teams design, test, and validate new platforms and medical devices in a regulatory-ready setting that speeds safe, global adoption.

ASI connects clinicians, scientists, engineers, and universities with IRBs and streamlined regulatory pathways so innovation meets global standards and translates into real patient benefit.

On the ASI campus, surgeons, scientists, and industry partners advance AI-guided surgery, robotics, telemedicine, and biomedical innovation—moving ideas from lab to OR and from data to patient impact.
ASI unites an 8K telecollaboration hall linked to CYNTAR ORs, modular AI-enabled surgical suites, a broadcast studio, and UCSD–UABC–Oxford collaborations.
ASI operates as a biohub where biotech, bioengineering, bioindustry, and clinical medicine intersect.
Its mission is to empower healthcare professionals with cutting-edge skills, tools, and knowledge that enable safer, smarter, and more efficient care.






Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Start with a quick form and get a custom roadmap for your learning.
Get informed with our Blog, News & Insights in one place.